Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Depreciation & Amortization (CF) (2016 - 2017)

Historic Depreciation & Amortization (CF) for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $24.0.

  • Bone Biologics' Depreciation & Amortization (CF) fell 4000.0% to $24.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $96.0, marking a year-over-year decrease of 8628.57%. This contributed to the annual value of $50.0 for FY2019, which is 4791.67% down from last year.
  • Latest data reveals that Bone Biologics reported Depreciation & Amortization (CF) of $24.0 as of Q4 2017, which was down 4000.0% from $24.0 recorded in Q3 2017.
  • Bone Biologics' Depreciation & Amortization (CF)'s 5-year high stood at $580.0 during Q1 2016, with a 5-year trough of $24.0 in Q1 2017.